Skip to content
10-Q

Quarterly Report

Kronos Bio, Inc.

0001741830-24-000050

← back to feed
Filed
Aug 8, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 2, 2024 60.29M sh
Shares Diluted Q2 2024 · Jun 30, 2024 60.1M sh
Shares Diluted Q2 2024 · Jun 30, 2024 59.81M sh
Shares Diluted Q2 2024 · Jun 30, 2023 57.4M sh
Shares Diluted Q2 2024 · Jun 30, 2023 57.27M sh
Capex Q2 2024 · Jun 30, 2024 $7K
Capex Q2 2024 · Jun 30, 2023 $434K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$40.23M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$30.97M
Short Term Investments Q2 2024 · Jun 30, 2024 $66.44M
Short Term Investments Q2 2024 · Dec 31, 2023 $108.67M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $70.21M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $64.33M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $44.4M
Stockholders Equity Q2 2024 · Jun 30, 2024 $123.15M
Stockholders Equity Q2 2024 · Mar 31, 2024 $136.97M
Stockholders Equity Q2 2024 · Dec 31, 2023 $159.08M
Stockholders Equity Q2 2024 · Jun 30, 2023 $203.34M
Stockholders Equity Q2 2024 · Mar 31, 2023 $225.61M
Stockholders Equity Q2 2024 · Dec 31, 2022 $244.5M
Current Liabilities Q2 2024 · Jun 30, 2024 $16.64M
Current Liabilities Q2 2024 · Dec 31, 2023 $24.7M
Total Liabilities Q2 2024 · Jun 30, 2024 $41.13M
Total Liabilities Q2 2024 · Dec 31, 2023 $54.2M
Current Assets Q2 2024 · Jun 30, 2024 $141.19M
Current Assets Q2 2024 · Dec 31, 2023 $178.78M
Total Assets Q2 2024 · Jun 30, 2024 $164.27M
Total Assets Q2 2024 · Dec 31, 2023 $213.28M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.27
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.77
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.52
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.98
Eps Basic Q2 2024 · Jun 30, 2024 −$0.27
Eps Basic Q2 2024 · Jun 30, 2024 −$0.77
Eps Basic Q2 2024 · Jun 30, 2023 −$0.52
Eps Basic Q2 2024 · Jun 30, 2023 −$0.98
Sga Expense Q2 2024 · Jun 30, 2024 $6.37M
Sga Expense Q2 2024 · Jun 30, 2024 $13.87M
Sga Expense restated Q2 2024 · Jun 30, 2023 $10.31M
Sga Expense restated Q2 2024 · Jun 30, 2023 $20.36M
Rd Expense Q2 2024 · Jun 30, 2024 $13.77M
Rd Expense Q2 2024 · Jun 30, 2024 $27.99M
Rd Expense restated Q2 2024 · Jun 30, 2023 $20.81M
Rd Expense restated Q2 2024 · Jun 30, 2023 $40.47M
Net Income Q2 2024 · Jun 30, 2024 −$16.2M
Net Income Q2 2024 · Jun 30, 2024 −$46.16M
Net Income Q2 2024 · Mar 31, 2024 −$29.96M
Net Income Q2 2024 · Jun 30, 2023 −$29.74M
Net Income Q2 2024 · Jun 30, 2023 −$55.98M
Net Income Q2 2024 · Mar 31, 2023 −$26.24M
Operating Income Q2 2024 · Jun 30, 2024 −$18.02M
Operating Income Q2 2024 · Jun 30, 2024 −$50.02M
Operating Income Q2 2024 · Jun 30, 2023 −$32.17M
Operating Income Q2 2024 · Jun 30, 2023 −$60.66M
Revenue Q2 2024 · Jun 30, 2024 $2.69M
Revenue Q2 2024 · Jun 30, 2024 $5.21M
Revenue Q2 2024 · Jun 30, 2023 $1.86M
Revenue Q2 2024 · Jun 30, 2023 $3.08M